During the past decade, Uniklinik Mainz; I. Medizinische Klinik conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uniklinik Mainz; I. Medizinische Klinik" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Johannes Gutenberg University Mainz" with 2 trials sponsored, "University Medical Center Mainz" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Actelion" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniklinik Mainz; I. Medizinische Klinik" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "Johannes Gutenberg University Mainz" with 1 trials as a collaborator and "Leap Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Uniklinik Mainz; I. Medizinische Klinik" are "Carcinoma, Hepatocellular" (1 trials), "Chronic Hepatitis B" (1 trials), "Coronary Arteriosclerosis" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Artery Restenosis" (1 trials). Many other conditions were trialed in "Uniklinik Mainz; I. Medizinische Klinik" in a lesser frequency.

Most popular intervention types in "Uniklinik Mainz; I. Medizinische Klinik" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sorafenib" (3 trials), "Atezolizumab" (2 trials), "Placebo" (2 trials), "Apheresis therapy by Octo Nova Technology (DIAMED, Cologne, Germany)" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uniklinik Mainz; I. Medizinische Klinik" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Uniklinik Mainz; I. Medizinische Klinik". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Uniklinik Mainz; I. Medizinische Klinik, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Uniklinik Mainz; I. Medizinische Klinik, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".